GSK-funding of storage and stability study for GSK filled ASO3 adjuvant under contract HHSO100200800071I (POP 1 1 2011 to 12 31 11) (522 700 vials) (can 1994010)

Ended Awarded Last action

Contract number
HHSO10033008T
Awardee
Awarding agency
Obligated
$44,430

Award facts

Opportunity
  • RFPHHSBARDA0825 Solicitation number
Contract value 100% obligated
$44,429.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Marietta, PA 17547, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 1 $13,068
Original award $31,362

Quick answers

Who was awarded contract HHSO10033008T?

HHSO10033008T was awarded to Glaxosmithkline Holdings (Americas) Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 1, 2011.

How much is contract HHSO10033008T worth?

The government has obligated $44,430 on HHSO10033008T.

Is contract HHSO10033008T an order under another contract?

Yes. HHSO10033008T is a delivery order under HHSO100200800071I, an indefinite delivery contract.

Was contract HHSO10033008T competed?

The extent of competition for HHSO10033008T was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award